Shunxi Holding Group

Company Deals

Shunxi Holding Group Secures Licensing Deal for Cartherics’ CTH-004 in Greater China

Fineline Cube May 8, 2023

China-based Shunxi Holding Group Co. Ltd has entered into a licensing deal with Australia-based firm...

Company Deals Drug

MacroGenics Secures $24.5M Milestone from Sanofi Following FDA Approval Expansion for Tzield in Type 1 Diabetes

Company Drug

Pfizer Reports Mixed Phase 3 Results for Sigvotatug Vedotin in Non-Small Cell Lung Cancer

Policy / Regulatory

Anhui Province Launches National Alliance for Monoclonal Antibody Biologics Volume-Based Procurement

Company Deals

Antengene Corporation Secures $980M Global Licensing Deal with K2 Therapeutics for CDH6×CD3 Bispecific T-Cell Engager